Leset

Quick links to important sections

Leset

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Leset

Property Description
Active Ingredient Levocetirizine Dihydrochloride
Form Oral tablet, oral solution, oral drops
Pharmacological Class Second-generation H1-receptor antagonist
General Purpose Mitigation of allergic symptoms
Origin Synthetic compound (chemically derived)

What is Leset and Its Pharmacological Classification?

Leset is a pharmaceutical product containing the active substance, Levocetirizine Dihydrochloride, which is pharmacologically classified as a second-generation H1-receptor antagonist. This class of medicine is designed to manage allergic responses by counteracting the effects of histamine, the natural chemical responsible for immediate allergy symptoms. The drug is a synthetic compound and a single-ingredient product, and it is clinically recognized for its high potency and rapid absorption rate. Its status as a second-generation compound differentiates it from older antihistamines, as pharmacological studies confirm its design to prioritize peripheral selectivity, thus minimizing the non-targeted sedative effects.

Composition and Available Forms of Leset

Levocetirizine Dihydrochloride is quickly absorbed following oral intake. The chemical core of Leset is Levocetirizine, specifically the pure, active R-enantiomer of Cetirizine. This isolated form, belonging to the piperazine derivatives group, is a key differentiating feature that contributes to its targeted therapeutic action. Leset is prepared for oral administration and is available in several oral dosage form(s), including the film-coated tablet and a liquid oral solution, positioning it for flexible use.

General Purpose of Levocetirizine Therapy

The general purpose of using Levocetirizine is to achieve precise antiallergic action. The drug's mechanism involves selective H1-receptor inverse agonism, stabilizing the receptor in an inactive state to prevent histamine from generating a response. This primary function is utilized in managing the uncomfortable physiological symptoms that arise from allergic episodes, such as widespread itching and localized swelling, which is a typical neutral use scenario for this class of medicine.

What side effects are possible with Leset?

Possible Side Effects and Safety Information

The safety profile for Leset (levocetirizine dihydrochloride) is structured by government regulatory agencies based on frequency and impact on physiological systems. The most frequently reported adverse reactions are related to the Nervous System and General Disorders.


Frequency-Classified Adverse Reactions

Adverse reactions are grouped by their reported incidence in clinical trials:

  • Common Reactions (occurring in 1/100 to < 1/10 of users) include Somnolence (drowsiness/sleepiness), Headache, Fatigue, Dry mouth, and Pharyngitis (throat inflammation).
  • Uncommon Reactions (occurring in 1/1,000 to < 1/100 of users) include Asthenia (weakness) and Abdominal pain.

Serious and Safety-Related Considerations

Rare but clinically significant adverse reactions have been documented. These include rare Immune System Disorders such as Hypersensitivity reactions, including Anaphylaxis, and rare reports of Hepatitis and Convulsions.

Population-Specific Limitations and Safety Patterns

The medicine is contraindicated in patients with end-stage renal disease (creatinine clearance less than 10 mL/ min) and in those undergoing hemodialysis, as levocetirizine is substantially excreted by the kidneys. Caution is advised for Older Adults (65 years and older) due to the higher potential for age-related decrease in renal function. The concurrent use of alcohol or other Central Nervous System (CNS) depressants may cause additional reductions in alertness. Official labeling also includes safety notes regarding Urinary retention and post-marketing reports of new or worsening Pruritus (itching) upon discontinuation after long-term use.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents mandate that individuals seek immediate medical attention and contact emergency services or a poison control center if a Leset (levocetirizine dihydrochloride) overdose is suspected.

Overconsumption of this medicine is primarily associated with Central Nervous System (CNS) effects. The typical presentation of an overdose in adults involves pronounced drowsiness (somnolence) and sedation. In the pediatric population, the clinical manifestation is officially noted to differ, often starting with agitation and restlessness before the onset of drowsiness.

Official Regulatory Management

Management of levocetirizine overdose is officially defined as symptomatic and supportive treatment. Regulatory information states that no specific antidote is known for this substance. Procedures such as gastric lavage and the administration of activated charcoal are described as measures that may be considered by medical professionals following excessive oral ingestion. Furthermore, official documents explicitly confirm that the drug is not effectively removed by hemodialysis, restricting clinical management to supportive care measures.

Therapeutic Uses of Leset

What Leset Treats: Main Uses and Benefits

Leset is applied across domains where additional symptomatic support is needed, contributing to easing the symptom load when manifestations become noticeable or persistent. The medicine is used to help manage symptoms associated with both allergic rhinitis and chronic idiopathic urticaria.


This medication is relevant for easing symptoms related to allergic rhinitis (hay fever and perennial allergies) and is applied in clinical settings marked by dermal hypersensitivity arising from chronic hives. It is used to help address symptom clusters that may become disruptive, including constant sneezing, runny nose (rhinorrhea), intense nasal itching, and nasal congestion, as well as widespread body itching (pruritus) and the presence of hives (wheals).

“The primary goal is to provide supportive relief that helps patients cope more steadily with these difficult, recurrent episodes of discomfort.”

Addressing these symptoms helps maintain a sense of stability when manifestations are more noticeable and supports general well-being during symptomatic phases. It is also used to help with associated ocular symptoms, relevant for easing manifestations like itchy eyes, redness, and watering/tearing of the eyes.


Quick Fact: Supportive Management of Nasal Congestion The medication is considered relevant for addressing the nasal blockage or congestion in allergic rhinitis, assisting with maintaining functional stability.

Eligibility and Restrictions for Use

Who can and cannot use Leset?

The official regulatory profile for Leset (levocetirizine dihydrochloride) defines specific eligibility criteria based on patient characteristics and clinical status.

Contraindicated Populations

Leset is contraindicated for any patient with a known hypersensitivity to levocetirizine, its parent compound cetirizine, hydroxyzine, or any piperazine derivatives. It is also absolutely prohibited for patients with End-Stage Renal Disease (Creatinine Clearance less than 10 mL/min) and for pediatric patients (6 months to 11 years) with impaired renal function.

Condition-Specific Eligibility Rules

  • Renal Function: Eligibility is conditional for adults and adolescents with mild, moderate, or severe renal impairment. Use requires a mandatory dose adjustment based on the degree of reduced function.
  • Other Conditions: Patients with predisposing factors for urinary retention must use the medication with caution. The tablet formulation is restricted for those with certain hereditary metabolic disorders.
  • Age Limits: Use is established from 6 months of age using the oral solution, but the film-coated tablet is not recommended for children under 6 years.
  • Pregnancy/Lactation: Use may be considered during pregnancy, if necessary, but it is not recommended while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Leset, which contains Levocetirizine Dihydrochloride, has formally documented interaction patterns established through regulatory assessment. These patterns include pharmacokinetic modifications, pharmacodynamic additive effects, and specific population-based restrictions related to drug clearance.


Pharmacodynamic and CNS Effects

Co-administration with alcohol and other Central Nervous System (CNS) depressants, such as sedatives or tranquilizers, should be avoided. This restriction is documented due to the risk of additive effects that can cause additional reductions in alertness and additional impairment of central nervous system performance.


Pharmacokinetic Modifications

Regulatory studies have identified specific pharmacokinetic (PK) interactions. Co-administration with Ritonavir resulted in a significant increase in systemic exposure (AUC) and a decrease in the clearance of the parent compound (cetirizine). Similarly, co-administration with a multiple dose of Theophylline also led to a documented decrease in the clearance of the parent compound. Studies with several common medications, including Ketoconazole, Erythromycin, and Cimetidine, showed no clinically relevant adverse interactions.


Restrictions and Food Interaction

Use of Leset is contraindicated in patient populations with end-stage renal disease or those undergoing hemodialysis. This formal restriction exists because the drug is primarily cleared by the kidneys, and severe impairment leads to substantially increased drug exposure. Regarding food, the official assessment notes that while food does decrease the rate of absorption of Levocetirizine, it does not reduce the total extent of absorption.

Mechanism of Action

Leset (Levocetirizine Dihydrochloride) is a selective pharmaceutical designed to modulate specific signaling pathways related to heightened physiological responses. Its primary mechanism involves acting as an inverse agonist at the peripheral Histamine H1-receptor. This action stabilizes the receptor in an inactive conformation, functionally shutting down the histamine-driven Gq protein signaling cascade and inhibiting the cellular cascade. By suppressing the H1-receptor signal on endothelial cells and smooth muscle tissue, Leset’s mechanism directly controls key physiological processes. This modulation reduces the histamine-induced increase in vascular permeability and vasodilation, contributing to the physiological stabilization of the systemic vascular system and reducing the histamine-mediated increase in fluid extravasation into peripheral tissues. The drug also engages a secondary mechanism by modulating specific chemokines like Eotaxin and RANTES. This influences the signaling that drives the attraction of eosinophils and other inflammatory cells to tissue sites, thereby modulating the downstream effect of chemokine activity on the underlying physiological response.

Dosage and Administration Information

Instruction Map: How to use Leset — Administration Guidelines

This map outlines the administration guidelines for Leset (levocetirizine dihydrochloride), focusing on procedural usage rules.


Administration Scope

Feature Guideline
Route of Administration Oral.
Dosing Schedule Adults (Age 12+): Recommended 5 mg once daily. Max 5 mg per day. Children (Age 6–11): Recommended 2.5 mg once daily. Max 2.5 mg per day.
Timing in Relation to Meals May be taken with or without food.
Preparation Requirements Oral Solution: Requires measurement using a calibrated device. Tablets: Scored tablets may be broken to administer 2.5 mg.
Age-Group Administration Rules Renal Impairment: Dosing intervals are individualized based on creatinine clearance (CLCR) for patients 12 and older (e.g., 2.5 mg once daily for mild impairment, 2.5 mg twice weekly for severe impairment). Hepatic Impairment (Solely): No dose adjustment is required.
Missed-Dose Rules
Special Procedural Conditions The dose is typically recommended to be administered in the evening. The maximum daily dose for the respective age group must not be exceeded.

Instruction Classifications (High-Level)

Classification Parameter
Administration method type Oral.
Frequency pattern Once daily (QD) or intermittent/as-needed use, depending on the condition being managed.
General classification Pharmaceutical administration protocol.
Use-context constraints Renal function status (requiring dosage adjustment); Age group (determining dose level); Condition type (determining duration pattern).

Resulting Procedural Structure

Procedural Step Sequence:

  • Select the appropriate dose based on age and renal function, adhering to the 5 mg daily adult maximum.
  • Take the dose orally (tablet or measured solution) with or without consuming food.
  • Administer the dose once daily, typically in the evening.

Connection to the Overall Use Protocol

This protocol defines a standardized, single-daily oral intake that is adjusted for renal function to ensure appropriate systemic exposure. The duration of use is guided by the distinction between short-term or intermittent use and the option for continuous use for up to six months of clinical experience.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical research on Levocetirizine (the active component of Leset) primarily consists of randomized, double-blind, placebo-controlled trials. These studies, considered a common research design in medicine, have investigated the compound's use across several allergic conditions, including seasonal and perennial allergic rhinitis, as well as chronic idiopathic urticaria (hives).


Key Areas of Investigation

Studies have focused on whether Levocetirizine affects the symptoms caused by histamine, a chemical messenger released during allergic responses. The research aims to evaluate outcomes such as reduction in sneezing, nasal congestion, runny nose, and itchy, watery eyes, which are common manifestations of allergic rhinitis. Further investigation has also examined its role in alleviating itching and swelling associated with hives.

Efficacy and Onset

Clinical evidence indicates that Levocetirizine acts as a selective antagonist of the peripheral H1-receptor. Trials examining the drug’s effectiveness report that symptom relief is typically observed within one hour of administration in most studied populations. Furthermore, the molecule’s pharmacological profile supports once-daily dosing, as studies have investigated the drug's action over a 24-hour period, suggesting sustained control of allergic symptoms.

Safety Profile

The safety profile of Levocetirizine has been extensively evaluated in clinical trials. Reported adverse events are generally categorized as mild and temporary. Commonly investigated side effects in the research include somnolence (sleepiness), fatigue, dry mouth, and headache. In comparisons with some older antihistamines, the risk of sedation reported in studies of Levocetirizine is often described as minimal.

Key Studies & References

  1. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Levocetirizine Dihydrochloride (Pharmacodynamics and safety profile discussion)

Frequently Asked Questions (FAQ)

Common questions about Leset (FAQ)


Q: Why is Leset prescribed instead of other similar drugs?

Official product information describes the active ingredient in Leset as the major pharmacologically active R-enantiomer of cetirizine. This specific chemical form is a key distinction from other similar compounds. This characteristic contributes to the drug’s targeted therapeutic action and is noted for its beneficial pharmacological profile.


Q: Does Leset cause long-term side effects that official sources don't mention?

Official sources, including drug labels and post-marketing safety data, are used to document all known side effects. These reports include those that occur upon the discontinuation of Leset after long-term use, such as instances of pruritus (severe itching). All safety information provided is based strictly on these regulatory documents and studies.


Q: Can Leset be taken with common over-the-counter pain relievers?

Official interaction studies available in regulatory documents do not typically list specific common over-the-counter pain relievers as having a documented clinically relevant interaction with the drug. The absence of a specific interaction in regulatory documentation suggests a major adverse interaction has not been established in required studies.


Q: What happens if I accidentally miss a dose of Leset?

The official guidance typically states that if a dose is missed, the next dose should be taken at the regularly scheduled time (usually the following evening). Official information generally cautions against taking a double dose to make up for the one that was missed.


Q: Does Leset have any known interaction with caffeine or coffee?

Regulatory documents and official product information do not list caffeine or coffee as having a documented, clinically relevant interaction with Leset.


Q: What does 'Leset is an antagonist' mean in simple terms?

Official documents describe Leset as a second-generation H₁-receptor antagonist. This mechanism is understood to work by specifically blocking the effects of histamine, which is a natural chemical in the body responsible for many immediate allergic symptoms.


Q: Does Leset interact with herbal supplements like St. John's Wort?

Official interaction studies and regulatory documents do not specifically list St. John's Wort or most other herbal supplements as having a documented interaction with Leset.


Q: Is Leset habit-forming or addictive?

According to regulatory classifications, the active ingredient in Leset is not classified as a controlled substance. Official labeling and safety documents do not indicate a risk for abuse or physical dependence associated with its use.


Q: How long does Leset stay in your system after you stop taking it?

Official pharmacokinetic studies indicate that the drug is eliminated from the body primarily by the kidneys. In adults with normal kidney function, the mean terminal half-life (the time it takes for half the drug to be eliminated) is reported as approximately 7 to 10 hours.


Q: Are there different versions or brands of Leset, and are they all the same?

The active ingredient, levocetirizine dihydrochloride, is available under various brand names and as generic versions. Official regulatory bodies require all generic formulations to meet the same quality and performance standards as the original brand-name product.


Q: What should I do if the side effects of Leset seem unusual or unexpected?

The official reporting system requires the manufacturer to maintain systems for tracking all adverse reactions. In the event of unusual or unexpected effects, official safety information directs that a health professional should be consulted regarding the reaction.


Q: Does research evidence show that Leset works better for certain groups of people?

Clinical trials have primarily focused on establishing the drug's effectiveness across various populations suffering from allergic conditions. Regulatory documents do not generally claim superiority or differential effectiveness for specific demographic groups, such as based on race or gender, over others.


Q: Can Leset be used by elderly people (over 65)?

Official guidance notes that use is possible for older adults (65 years and older). However, caution is advised due to the higher potential for age-related decrease in renal (kidney) function, which may require an adjustment in administration.


Q: Are there any specific activities or hobbies I should avoid while taking Leset?

Official product labeling contains a caution regarding activities that require complete mental alertness, such as driving a motor vehicle or operating hazardous machinery. This caution is noted because the drug has the potential to cause somnolence (drowsiness).


Q: Why do some people say Leset made them feel differently right away, but others didn't?

Clinical studies indicate that symptom relief is typically observed within one hour of administration in most studied populations. Official evidence acknowledges that despite a common time frame, the individual physiological response to the drug can vary from person to person.


Q: Can Leset affect the results of lab tests, like blood work?

Official documentation, including warnings and precautions, does not contain a specific warning regarding the drug's potential to interfere with common clinical laboratory tests, such as routine blood work.


Q: Why is Leset sometimes discontinued quickly by patients?

Regulatory documents on clinical trial data indicate that a primary reason for patient discontinuation is the experience of common side effects such as somnolence (drowsiness) and fatigue, which are the most frequently reported adverse reactions.


Q: What is the likelihood of developing a serious side effect from Leset?

Serious adverse reactions, such as anaphylaxis, hepatitis, and convulsions, are documented in official safety information. These reactions are classified as rare or noted in post-marketing experience, indicating that they do not occur commonly in the studied population.


Q: Does Leset have any known effects on fertility or reproductive health?

Reports from animal studies suggest a lack of evidence of reproductive toxicity associated with the active ingredient. Official documentation addresses use during pregnancy and lactation separately.


Q: What kind of evidence supports the long-term use of Leset?

Official documents and clinical experience support the use of Leset for continuous periods of up to six months for specific conditions. This duration is defined by the official protocol distinction between short-term use and continuous therapeutic administration.


Q: Why is Leset not recommended for children or teenagers?

Official guidance states that the film-coated tablet formulation is not recommended for children under 6 years of age. Furthermore, use in pediatric patients from 6 months to 11 years is contraindicated if they have impaired renal (kidney) function.


Q: What does the patient information leaflet say are the signs of an allergic reaction to Leset?

Official safety documentation notes that hypersensitivity reactions, including a severe reaction known as anaphylaxis, have been reported. Signs often associated with serious reactions include swelling of the face, tongue, or throat, or difficulty breathing.


Q: Are there any warnings about combining Leset with cold or flu medicines?

Official warnings state that co-administration with Central Nervous System (CNS) depressants is to be avoided. Cold and flu medicines may sometimes contain these ingredients, creating a risk of additive effects that can increase drowsiness or reduce mental alertness.


Q: What information is publicly available about the clinical trials for Leset?

Information regarding the clinical trials that supported the drug's approval is typically made publicly available. This information is accessible through official regulatory bodies like the FDA or EMA.


Q: Does Leset interact with birth control pills?

Official drug interaction studies, as described in regulatory documents, do not list an interaction between the active ingredient in Leset and oral contraceptive medications.


Q: What happens if Leset is taken at the same time as a blood pressure medication?

Official interaction studies available in regulatory documents do not list specific blood pressure medications (such as ACE inhibitors or beta-blockers) as having a documented clinically relevant interaction with the drug.


Q: Are generic versions of Leset exactly the same as the brand name?

Generic versions containing the active ingredient, levocetirizine dihydrochloride, are required by regulatory bodies to be bioequivalent to the brand-name product. This means they are expected to work in the body in the same way and provide the same therapeutic effect.

How should Leset be stored and disposed of?

The storage and disposal of Leset (levocetirizine dihydrochloride) must adhere to the conditions outlined in official regulatory documents to ensure product stability and safety.

Storage Requirements

Condition Regulatory Mandate
Temperature Store at Controlled Room Temperature, between 20 C and 25 C (68 F and 77 F)
Protection Store in a dry place and keep the oral solution from freezing
Container Keep the medicine in a closed container and do not use it after the expiry date
Child Safety Must be kept out of the sight and reach of children

Disposal Instructions

Official disposal rules prohibit throwing the medicine away via wastewater or household waste. Unused or expired product and waste material must be disposed of in accordance with local requirements. Patients can consult a pharmacist for guidance on safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Leset found in:

A-Z Index: